Active Pharmaceutical Ingredient:
Antithrombotic agents, thrombocyte aggregation inhibitors excl. heparin
Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) to improve resilience and alleviate disease symptoms in patients with New York Heart Association (NYHA) functional class III.
Trisuva is used in adults (18 years of age and older).
One 10 ml vial available in 3 concentrations:
- 2.5 mg/ml
- 5 mg/ml
- 10 mg/ml